February 8, 2021
Izzo NJ et al. Alzheimer’s Dement 2021;1–18.
Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification
Download publication
You might also be interested by
Posters
Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues
November 9, 2020
Proteomics/Mass Spectrometry
More infoPosters
Quantification of sBCMA in Human Plasma using a High-Throughput Mass Spectrometry Workflow for Exploratory, CAP/CLIA or Regulated Studies
November 9, 2020
Proteomics/Mass Spectrometry
More infoPosters
Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)
July 29, 2020
Proteomics/Mass Spectrometry
More infoInsight from our experts
Insight From Our Experts:
Discussing MHC Peptide Analysis with Eustache Paramithiotis
July 13, 2020
Proteomics/Mass Spectrometry
More info